Fig. 3: Kaplan–Meier plots for disease-free survival in patients with stage II/III CRC according to TIL status.

Patients are grouped into (a–c) individuals with mucinous/mucinous component tumours, (d–f) individuals with non-mucinous tumours for (a, d) the entire cohort, (b, e) dMMR tumour, and (c, f) pMMR tumours. TIL, tumour infiltrating lymphocyte; dMMR DNA mismatch repair deficient, pMMR DNA mismatch repair proficient; *p < 0.050.